Medication overuse headache: a review of current evidence and management strategies.
diagnosis
headache chronification
managment
medication overuse headache
migraine headache
symptoms
Journal
Frontiers in pain research (Lausanne, Switzerland)
ISSN: 2673-561X
Titre abrégé: Front Pain Res (Lausanne)
Pays: Switzerland
ID NLM: 9918227269806676
Informations de publication
Date de publication:
2023
2023
Historique:
received:
26
03
2023
accepted:
18
07
2023
medline:
24
8
2023
pubmed:
24
8
2023
entrez:
24
8
2023
Statut:
epublish
Résumé
The third edition of the International Classification of Headache Disorders (ICHD-3) defines medication-overuse headache (MOH) as a headache that develops when a person regularly uses acute or symptomatic headache medications excessively (10 or more, or 15 or more days per month, depending on the medication) for a period of time longer than 3 months. Even though it may not be reported as frequently as it actually is, it affects about 5% of the general population on average. It typically happens following repeated anti-pain medication use for pre-existing headache disorders, such as migraines. Anti-pains can also be used frequently in patients with pre-existing headache disorders for reasons other than treating headaches, such as psychological drug attachment. MOH is linked to a number of illnesses, such as anxiety, depression, and obsessive compulsive disorder (OCD). Both simple and complex types are possible. Additionally, there is no universal consensus on how to treat MOH, but drug discontinuation is the best course of action. Using the medical subject headings "Medication Overuse Headache," "Migraine Headache," "Tension Headache," "Chronification of Headache," and "Antipains," an all-language literature search was done on PubMed, Google Scholar, and Medline up until March 2023. We looked into the epidemiology, risk factors, pathophysiology, clinical characteristics, comorbidities, diagnosis, management, and preventative measures of MOH in the literature. This article focuses on the MOH research themes.
Identifiants
pubmed: 37614243
doi: 10.3389/fpain.2023.1194134
pmc: PMC10442656
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1194134Informations de copyright
© 2023 Kebede, Mohammed, Tamene, Abebe and Dhugasa.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Neurology. 2008 Nov 25;71(22):1821-8
pubmed: 19029522
J Headache Pain. 2015;16:83
pubmed: 26382855
Neurol Sci. 2011 May;32 Suppl 1:S177-9
pubmed: 21533740
Cephalalgia. 2011 Jul;31(9):1015-22
pubmed: 21628444
Cephalalgia. 2014 May;34(6):409-25
pubmed: 24293089
Cephalalgia. 2018 Jan;38(1):1-211
pubmed: 29368949
Curr Pain Headache Rep. 2009 Aug;13(4):319-25
pubmed: 19586597
Eur J Neurol. 2011 Jan;18(1):129-37
pubmed: 20528911
Cephalalgia. 2011 Aug;31(11):1189-98
pubmed: 21700646
Eur J Neurol. 2011 Mar;18(3):396-401
pubmed: 20629723
Lancet. 2015 Aug 22;386(9995):743-800
pubmed: 26063472
Dtsch Arztebl Int. 2018 Jun 1;115(22):365-370
pubmed: 29932046
Cephalalgia. 2006 Sep;26(9):1097-105
pubmed: 16919060
J Neurol Neurosurg Psychiatry. 2009 Jul;80(7):784-9
pubmed: 19279030
J Headache Pain. 2007 Oct;8 Suppl 1:S3-47
pubmed: 18034215
Lancet. 2016 Oct 8;388(10053):1545-1602
pubmed: 27733282
Cephalalgia. 2010 Feb;30(2):207-13
pubmed: 19489879
Curr Pain Headache Rep. 2012 Feb;16(1):110-5
pubmed: 22076674
Ther Adv Drug Saf. 2014 Apr;5(2):87-99
pubmed: 25083264
Neurology. 2000 Jan 25;54(2):314-9
pubmed: 10668689
Headache. 2008 Jan;48(1):26-31
pubmed: 18184282
Can J Ophthalmol. 2008 Aug;43(4):432-4
pubmed: 18711457
Headache. 2010 Oct;50(9):1464-72
pubmed: 20572880
Lancet. 2017 Sep 16;390(10100):1211-1259
pubmed: 28919117
Eur J Neurol. 2010 Nov;17(11):1318-25
pubmed: 20482606
Neurology. 2003 Jul 22;61(2):160-4
pubmed: 12874392
Cephalalgia. 2012 Apr;32(5):373-81
pubmed: 22395797
Pain Rep. 2017 Jul 26;2(4):e612
pubmed: 29392227
Lancet Neurol. 2004 Aug;3(8):475-83
pubmed: 15261608
Brain. 2019 Jan 1;143(1):e6
pubmed: 31782777
Continuum (Minneap Minn). 2012 Aug;18(4):807-22
pubmed: 22868543
Headache. 2014 Jan;54(1):211-7
pubmed: 24116964
J Neurol Neurosurg Psychiatry. 2001 Mar;70(3):377-81
pubmed: 11181862
Headache. 2018 Apr;58(4):525-533
pubmed: 29235107
J Headache Pain. 2015 Dec;16(Suppl 1):A148
pubmed: 28132240
Eur J Neurol. 2016 Jan;23(1):85-91
pubmed: 26228376
Headache. 2000 May;40(5):343-50
pubmed: 10849027
Curr Pain Headache Rep. 2018 Jan 16;22(1):1
pubmed: 29340793
Headache. 1997 Jul-Aug;37(7):460-2
pubmed: 9277033
Eur J Neurol. 2015 Aug;22(8):1228-34
pubmed: 25981360
JAMA Neurol. 2020 Sep 1;77(9):1069-1078
pubmed: 32453406
J Headache Pain. 2016 Dec;17(1):107
pubmed: 27882516
J Headache Pain. 2012 Nov;13(8):615-24
pubmed: 23007859
Headache. 2010 Nov;50(10):1597-611
pubmed: 20807250
Brain. 2010 Aug;133(Pt 8):2475-88
pubmed: 20627971
Eur J Neurol. 2016 Jan;23 Suppl 1:28-35
pubmed: 26563095
Pain. 2011 Mar;152(3 Suppl):S2-S15
pubmed: 20961685
Headache. 1982 Mar;22(2):66-8
pubmed: 7085263
Pain. 2003 Nov;106(1-2):81-9
pubmed: 14581114
Pain. 2012 Jan;153(1):56-61
pubmed: 22018971
J Headache Pain. 2018 Jul 13;19(1):50
pubmed: 30003412
Cephalalgia. 2014 Feb 20;34(9):645-655
pubmed: 24558185
J Headache Pain. 2016;17:59
pubmed: 27245683
J Neurol Neurosurg Psychiatry. 2010 Nov;81(11):1261-4
pubmed: 20660917
Eur J Neurol. 2011 Sep;18(9):1115-21
pubmed: 21834901
Headache. 2003 Mar;43(3):179-90
pubmed: 12603636
Headache. 2009 Mar;49(3):412-8
pubmed: 19267785
Headache. 2011 Sep;51(8):1212-27
pubmed: 21884080
Ther Adv Drug Saf. 2016 Aug;7(4):147-58
pubmed: 27493718
Curr Pain Headache Rep. 2014 Jul;18(7):428
pubmed: 24898106
Neurology. 2002 Oct 8;59(7):1011-4
pubmed: 12370454
Headache. 2001 Mar;41(3):303-9
pubmed: 11264692
Cephalalgia. 2014 May;34(6):426-33
pubmed: 24322480
J Headache Pain. 2021 Apr 28;22(1):32
pubmed: 33910499
J Neurosci. 2009 Dec 16;29(50):15828-35
pubmed: 20016098